GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Modus Therapeutics Holding AB (FRA:99Z) » Definitions » Institutional Ownership

Modus Therapeutics Holding AB (FRA:99Z) Institutional Ownership : 0.02% (As of Mar. 30, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Modus Therapeutics Holding AB Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Modus Therapeutics Holding AB's institutional ownership is 0.02%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Modus Therapeutics Holding AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Modus Therapeutics Holding AB's Float Percentage Of Total Shares Outstanding is 0.00%.


Modus Therapeutics Holding AB Institutional Ownership Historical Data

The historical data trend for Modus Therapeutics Holding AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Modus Therapeutics Holding AB Institutional Ownership Chart

Modus Therapeutics Holding AB Historical Data

The historical data trend for Modus Therapeutics Holding AB can be seen below:

2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31
Institutional Ownership 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.02 0.02

Modus Therapeutics Holding AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Modus Therapeutics Holding AB Business Description

Traded in Other Exchanges
Address
Olof Palmes gata 29 IV, Stockholm, SWE, 111 22
Modus Therapeutics Holding AB is a Swedish clinical biotechnology company developing a treatment for sepsis, endotoxemia, severe malaria, and other disorders with severe systemic inflammation as well as states of anemia, related to chronic inflammation such as kidney diseases through its patented polysaccharide sevuparin. The drug candidate sevuparin has the opportunity to benefit patients and save large healthcare costs.

Modus Therapeutics Holding AB Headlines

No Headlines